Omalizumab in Practice: Ten-Year Experience of A Tertiary Referral Allergy Centre


Oztop N., Demir S., Beyaz S., Tuzer O. C., Colakoglu B., Buyukozturk S., ...More

ASTIM ALLERJI IMMUNOLOJI, vol.20, no.1, pp.36-47, 2022 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.21911/aai.647
  • Journal Name: ASTIM ALLERJI IMMUNOLOJI
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.36-47
  • Keywords: Anaphylaxis, ABPA, severe asthma, chronic spontaneous urticaria, mastocytosis, nasal polyposis, omalizumab, BRONCHOPULMONARY ASPERGILLOSIS, ASTHMA, GUIDELINE, THERAPY
  • Istanbul University Affiliated: Yes

Abstract

Objective: To evaluate the clinical outcome of omalizumab in various diseases.